linsidomine has been researched along with Carcinoma, Lewis Lung in 1 studies
linsidomine: RN given refers to parent cpd; structure
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, T | 1 |
| Ramakrishnan, R | 1 |
| Altiok, S | 1 |
| Youn, JI | 1 |
| Cheng, P | 1 |
| Celis, E | 1 |
| Pisarev, V | 1 |
| Sherman, S | 1 |
| Sporn, MB | 1 |
| Gabrilovich, D | 1 |
1 other study available for linsidomine and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Female; Humans; Inflammation Mediators; Interleuki | 2011 |